Tongji Hospital
Wuhan, Hubei, 430030, China
NCT Number: NCT03712657
This multicenter, prospective randomized controlled study is designed to applicate perioperative Enhanced recovery after surgery (ERAS) management for children with acute complicated appendicitis, the aim is to promote postoperative recovery, shorten the hospital length of stay, and reduce the incidence of postoperative complications.
Looking for future studies?
Notify Me1 year–14 year
All sexes
Interventional
Not applicable
Wuhan, Hubei, 430030, China
The purpose of this study is through multi-center prospective RCT research, to discuss the application of ERAS in children with acute complicated appendicitis, including its preoperative rehydration, postoperative analgesia, preoperative and postoperative antibiotics application, as well as the discharge standards and so on. The major outcome is whether it can reduce the length of stay in hospital (LOS), secondary outcomes are included the incidence of postoperative complications and postoperative readmission rate, etc.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, an average of 7 days
less hospital length of stay
Time frame: up to 72 hours
earlier postoperative feeding
Time frame: 1-2 days
earlier postoperative exercising
Time frame: 1 months
less postoperative complication
Time frame: 1 months
less rate of re-operation
Time frame: 1 months
less rate of re-admission
Feng Jiexiong
Other
Multi-center Research Manual for the Perioperative Application of Enhanced Recovery After Surgery in Pediatric Acute Appendicitis
Acronym: EPAA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03358446
Disease Attributes, Emergencies
Seoul, South Korea
View Trial DetailsNCT06489951
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT05590884
Body Indication, Central Nervous System Diseases
Cincinnati, Ohio, United States
View Trial DetailsNCT05762835
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Sacramento, California, United States
View Trial Details